To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
7 Current news about the topic creabilis therapeutics
rss
Creabilis appoints Dr Simon Russell as Chief Business Officer
07-05-2012
Creabilis SA announces that Dr Simon Russell has been appointed as Chief Business Officer. Dr Russell joins Creabilis from Novartis Pharma AG where he held a number global strategic marketing roles and most recently Head of Global Marketing for ILARIS (canakinumab). He was previously Head of ...
Creabilis Raises €15M in Series B Fundraising Round
05-10-2011
Creabilis SA has raised €15 million ($20 million) in a Series B funding round led by Abbott Biotech Ventures. Existing investors Neomed and Sofinnova Partners, as well as private Italian investors, joined the round. The new funds will be used to finance the development of the company’s ...
Creabilis appoints Dr David Roblin as Chief Medical Officer
08-08-2011
Creabilis SA announced that Dr David Roblin has been appointed Chief Medical Officer.Dr Roblin has gained extensive experience in the pharmaceutical industry in a career spanning more than 15 years and which has seen him deliver several drugs to the market. He has held leadership roles in ...
Creabilis Announces Positive Phase IIa Results for TrkA Kinase Inhibitor CT327 in Psoriasis Vulgaris
14-03-2011
Creabilis SA announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris. CT327 is a novel topically applied TrkA kinase inhibitor developed using Creabilis’ LSE (Low Systemic Exposure) technology. LSE technology creates new chemical entities with ideal ...
Creabilis Therapeutics Appoints Anthony Wilson as its New Chief Executive Officer
18-06-2008
Creabilis Therapeutics SpA announced the appointment of Tony Wilson as Chief Executive Officer with immediate effect. Mr Wilson brings to Creabilis a broad knowledge of the biotechnology and pharmaceutical industry combined with first hand experience of the dermatology sector. He has over 25 ...
Creabilis therapeutics SpA appoints Domenico Criscuolo as Chief Medical Officer
12-03-2007
Creabilis therapeutics SpA announced the appointment of Domenico Criscuolo as Chief Medical Officer, effective February 21st, 2007. Dr Criscuolo graduated in Medicine at the University of Rome and got a PhD in Haematology and another one in Clinical Oncology. He started working as Clinical ...
Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration
Improvement of HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies
15-11-2006
Nautilus Biotech SA and Creabilis Therapeutics SpA have announced that they have shown increased biological activity and resistance to proteolysis in vitro of the High Mobility Group Box One (HMGB1) Box A protein, an important technical milestone in their collaboration to identify a potential ...
Page 1 From 1
Netmeeting
